133 related articles for article (PubMed ID: 22126683)
1. Effect of maropitant, a neurokinin 1 receptor antagonist, on anesthetic requirements during noxious visceral stimulation of the ovary in dogs.
Boscan P; Monnet E; Mama K; Twedt DC; Congdon J; Steffey EP
Am J Vet Res; 2011 Dec; 72(12):1576-9. PubMed ID: 22126683
[TBL] [Abstract][Full Text] [Related]
2. Effect of maropitant, a neurokinin-1 receptor antagonist, on the minimum alveolar concentration of sevoflurane during stimulation of the ovarian ligament in cats.
Niyom S; Boscan P; Twedt DC; Monnet E; Eickhoff JC
Vet Anaesth Analg; 2013 Jul; 40(4):425-31. PubMed ID: 23406526
[TBL] [Abstract][Full Text] [Related]
3. Effect of epidural and intravenous use of the neurokinin-1 (NK-1) receptor antagonist maropitant on the sevoflurane minimum alveolar concentration (MAC) in dogs.
Alvillar BM; Boscan P; Mama KR; Ferreira TH; Congdon J; Twedt DC
Vet Anaesth Analg; 2012 Mar; 39(2):201-5. PubMed ID: 22103569
[TBL] [Abstract][Full Text] [Related]
4. A dog model to study ovary, ovarian ligament and visceral pain.
Boscan P; Monnet E; Mama K; Twedt DC; Congdon J; Eickhoff JC; Steffey EP
Vet Anaesth Analg; 2011 May; 38(3):260-6. PubMed ID: 21492392
[TBL] [Abstract][Full Text] [Related]
5. Interaction between maropitant and carprofen on sparing of the minimum alveolar concentration for blunting adrenergic response (MAC-BAR) of sevoflurane in dogs.
Fukui S; Ooyama N; Tamura J; Umar MA; Ishizuka T; Itami T; Miyoshi K; Sano T; Yamashita K
J Vet Med Sci; 2017 Mar; 79(3):502-508. PubMed ID: 28111373
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of maropitant, a novel neurokinin type-1 receptor antagonist, in dogs.
Benchaoui HA; Cox SR; Schneider RP; Boucher JF; Clemence RG
J Vet Pharmacol Ther; 2007 Aug; 30(4):336-44. PubMed ID: 17610407
[TBL] [Abstract][Full Text] [Related]
7. The neurokinin-1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model.
de la Puente-Redondo V; Tingley FD; Schneider RP; Hickman MA
J Vet Pharmacol Ther; 2007 Aug; 30(4):281-7. PubMed ID: 17610400
[TBL] [Abstract][Full Text] [Related]
8. Amitriptyline, minocycline and maropitant reduce the sevoflurane minimum alveolar concentration and potentiate remifentanil but do not prevent acute opioid tolerance and hyperalgesia in the rat: a randomised laboratory study.
Aguado D; Abreu M; Benito J; García-Fernández J; Gómez de Segura IA
Eur J Anaesthesiol; 2015 Apr; 32(4):248-54. PubMed ID: 24849503
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of induction characteristics and hypnotic potency of isoflurane and sevoflurane in healthy dogs.
Hofmeister EH; Brainard BM; Sams LM; Allman DA; Cruse AM
Am J Vet Res; 2008 Apr; 69(4):451-6. PubMed ID: 18380575
[TBL] [Abstract][Full Text] [Related]
11. Effect of nitrous oxide on the minimum alveolar concentration for sevoflurane and the minimum alveolar concentration derivatives that prevent motor movement and autonomic responses in dogs.
Seddighi R; Egger CM; Rohrbach BW; Hobbs M; Doherty TJ
Am J Vet Res; 2012 Mar; 73(3):341-5. PubMed ID: 22369524
[TBL] [Abstract][Full Text] [Related]
12. Effects of continuous intravenous infusion of morphine and morphine-tramadol on the minimum alveolar concentration of sevoflurane and electroencephalographic entropy indices in dogs.
Mahidol C; Niyom S; Thitiyanaporn C; Suprasert A; Thengchaisri N
Vet Anaesth Analg; 2015 Mar; 42(2):182-6. PubMed ID: 24962180
[TBL] [Abstract][Full Text] [Related]
13. Effects of constant rate infusions of dexmedetomidine or MK-467 on the minimum alveolar concentration of sevoflurane in dogs.
Hector RC; Rezende ML; Mama KR; Steffey EP; Knych HK; Hess AM; Honkavaara JM; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2017 Jul; 44(4):755-765. PubMed ID: 28734855
[TBL] [Abstract][Full Text] [Related]
14. Effects of intravenous administration of lidocaine on the minimum alveolar concentration of sevoflurane in horses.
Rezende ML; Wagner AE; Mama KR; Ferreira TH; Steffey EP
Am J Vet Res; 2011 Apr; 72(4):446-51. PubMed ID: 21453144
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous lidocaine, ketamine, and the combination on the minimum alveolar concentration of sevoflurane in dogs.
Wilson J; Doherty TJ; Egger CM; Fidler A; Cox S; Rohrbach B
Vet Anaesth Analg; 2008 Jul; 35(4):289-96. PubMed ID: 18363578
[TBL] [Abstract][Full Text] [Related]
16. Determination of minimum alveolar concentration of sevoflurane in juvenile swine.
Moeser AJ; Blikslager AT; Swanson C
Res Vet Sci; 2008 Apr; 84(2):283-5. PubMed ID: 17570452
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on minimum alveolar concentration (MAC) of sevoflurane in dogs.
YAMASHITA K; IWASAKI Y; UMAR MA; ITAMI T
J Vet Med Sci; 2009 Nov; 71(11):1509-12. PubMed ID: 19959903
[TBL] [Abstract][Full Text] [Related]
18. Effects of perzinfotel on the minimum alveolar concentration of isoflurane in dogs when administered as a preanesthetic via various routes or in combination with butorphanol.
Zwijnenberg RJ; del Rio CL; Pollet RA; Muir WW
Am J Vet Res; 2010 Jun; 71(6):604-9. PubMed ID: 20513173
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of injectable and oral maropitant, a selective neurokinin 1 receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs.
Ramsey DS; Kincaid K; Watkins JA; Boucher JF; Conder GA; Eagleson JS; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):538-43. PubMed ID: 19000277
[TBL] [Abstract][Full Text] [Related]
20. The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
Swallow A; Rioja E; Elmer T; Dugdale A
Vet Anaesth Analg; 2017 Jul; 44(4):785-793. PubMed ID: 28844293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
